Leerink Cuts Alnylam (ALNY) PT to $107

May 3, 2016 8:14 AM

Leerink Partners analyst, Michael Schmidt, recapped the Alnylam Pharmaceuticals (NASDAQ: ALNY) pipeline update from 1Q results and cut his price ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found